Diabetes Technology

Implantable Continuous Glucose Monitoring Device Safe, Effective for Adolescents

Implantable Continuous Glucose Monitoring Device Safe, Effective for Adolescents

By

The safety assessment included incidence of insertion or procedure-related removal and device-related serious adverse events through 180 after insertion.

First CGM System With Implantable Glucose Sensor Approved

First CGM System With Implantable Glucose Sensor Approved

By

The sensor is coated with a fluorescent chemical which produces a small amount of light when exposed to blood glucose.

FDA Clears Omnipod DASH System for Diabetes Management

FDA Clears Omnipod DASH System for Diabetes Management

By

The Omnipod DASH system consists of a discreet, tubeless, waterproof Pod which is worn on the body, and the Personal Diabetes Manager (PDM), a handheld wireless device used to control the Pod.

Asymptomatic Hypoglycemia Risk With Frequent Hypoglycemia in T1D

Asymptomatic Hypoglycemia Risk With Frequent Hypoglycemia in T1D

By

Investigators recorded hypoglycemic symptoms and monitored blood sugar levels by continuous glucose monitoring for 6 days.

Individuals With Type 1 Diabetes See Improvement With Continuous Glucose Monitoring

Individuals With Type 1 Diabetes See Improvement With Continuous Glucose Monitoring

By

Investigators seek to determine he effects of continuous glucose monitoring on daytime and nocturnal hypoglycemia in patients with type 1 diabetes.

Pharmacists Can Help With Diabetes Management via Telemedicine

Pharmacists Can Help With Diabetes Management via Telemedicine

Telemedicine could provide real-time feedback loop and allow pharmacists to help patients self-manage.

Continuous Glucose Monitoring Cost-Effective in Type 1 Diabetes

Continuous Glucose Monitoring Cost-Effective in Type 1 Diabetes

For adults with type 1 diabetes with suboptimal control despite using multiple insulin injections, continuous glucose monitoring seems cost-effective, with improved glucose control.

Risks and Benefits of FDA "Pre-Cert" Program for Medical Software Devices Examined

Risks and Benefits of FDA "Pre-Cert" Program for Medical Software Devices Examined

By

The FDA Digital Health Software Precertification Program represents a feasible solution to regulate software classified as a medical device.

FDA Approves Unique Device for Diabetic Retinopathy Screening

FDA Approves Unique Device for Diabetic Retinopathy Screening

By

This is the first device authorized for marketing that provides a screening decision without the need for clinician interpretation.

Accuracy of Novel Implantable Continuous Glucose Monitoring Device Assessed

Accuracy of Novel Implantable Continuous Glucose Monitoring Device Assessed

By

Researchers assessed the safety and accuracy of an implantable continuous glucose measurement in adults diagnosed with type 1 and type 2 diabetes.

New 'Smart' CGM System Provides Predictive Alerts to Patients With Diabetes

New 'Smart' CGM System Provides Predictive Alerts to Patients With Diabetes

By

Users also have access to the Company's Sugar.IQ app, which uses IBM's Watson Health platform, to identify glucose patterns based on factors that may affect them (ie, food intake, insulin dosages, daily routines).

Dexcom G6 Integrated Continuous Glucose Monitoring System Gets FDA Approval

Dexcom G6 Integrated Continuous Glucose Monitoring System Gets FDA Approval

By

The FDA reviewed data for the device through the de novo premarket review pathway, a regulatory pathway for novel, low-to-moderate-risk devices that are not substantially equivalent to an already legally marketed device.

Closed-Loop Insulin Delivery Offers Best Outcomes for Pregnant Women With T1D

Closed-Loop Insulin Delivery Offers Best Outcomes for Pregnant Women With T1D

For pregnant women with type 1 diabetes, a closed-loop system is associated with comparable glucose control and significantly less hypoglycemia than sensor-augmented pump therapy.

MiniMed 670G System Improves Glycemic Outcomes in Children With T1D

MiniMed 670G System Improves Glycemic Outcomes in Children With T1D

By

Research findings indicate improved glycemic outcomes in children with T1D using the MiniMed 670G system, similar to those observed for adolescents and adults.

Case for Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes

Case for Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes

By

An increasing number of studies support the use of continuous glucose monitoring in adult patients with T2D, and the observed benefits are likely to extend to youth with T2D.

Preventing Nocturnal Hypoglycemia: Single- vs Dual-Hormone Artificial Pancreas System

Preventing Nocturnal Hypoglycemia: Single- vs Dual-Hormone Artificial Pancreas System

By

Study suggests that single-hormone artificial pancreas systems may be sufficient for overnight control even in a high-risk group of hypoglycemia-unaware participants with documented nocturnal hypoglycemia.

Novel Deep Learning System May Help Identify Diabetic Retinopathy

Novel Deep Learning System May Help Identify Diabetic Retinopathy

A novel deep learning system has high sensitivity and specificity for identifying diabetic retinopathy.

Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined

Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined

By

In this phase 3 study, statistically and clinically meaningful improvements in HbA1c, body weight, and the proportion of patients achieving goal HbA1c <7% (53mmol/mol) were demonstrated with 2 doses of ITCA 650 vs placebo.

New Continuous Glucose Monitoring System Now Available for Medicare Patients

New Continuous Glucose Monitoring System Now Available for Medicare Patients

By

A new continuous glucose monitoring system that allows patients to capture real-time glucose readings without use calibration or routine fingersticks is now available.

New Insulin Pen With Smartphone App, Bolus Advisor Available

New Insulin Pen With Smartphone App, Bolus Advisor Available

By

The system is able to calculate and recommend optimal insulin dose, track the timing of doses, monitor insulin temperature, remind users to take insulin, and create reports for the healthcare provider.

New Consensus Recommendations on Use of Continuous Glucose Monitoring

New Consensus Recommendations on Use of Continuous Glucose Monitoring

By

The Advanced Technologies & Treatments for Diabetes (ATTD) Congress summarize consensus recommendations on the current understanding of how CGM results can affect outcomes.

Standard Care vs Telemedicine for Diabetic Foot Ulcer Follow-up Care

Standard Care vs Telemedicine for Diabetic Foot Ulcer Follow-up Care

By

Patients from 3 sites participated in a trial examining the noninferiority of telemedicine vs standard outpatient care for diabetic foot ulcer follow-up treatment.

Effect of SGLT2 Inhibitors on Early Metabolic Decompensation in T1D

Effect of SGLT2 Inhibitors on Early Metabolic Decompensation in T1D

By

Patients with T1D are not susceptible to accelerated lipolysis and ketogenesis, despite the reduction in overnight basal insulin doses during SGLT2i treatment.

Real-Time Continuous Glucose Monitoring Beneficial But Challenges Remain

Real-Time Continuous Glucose Monitoring Beneficial But Challenges Remain

By

Although sharing of real-time continuous glucose monitoring data can create tension between patients with type 1 diabetes and family members, it can also facilitate greater empowerment and perceptions of safety among both patients and their caregivers.

Predictive Glucose Management Systems May Reduce Hypoglycemia in Pediatric Diabetes

Predictive Glucose Management Systems May Reduce Hypoglycemia in Pediatric Diabetes

By

A study examined the efficacy and safety of predictive low-glucose management systems for the prevention of hypoglycemia in adolescents with type 1 diabetes.

Psychosocial Benefits of a Bihormonal Bionic Pancreas System in T1D

Psychosocial Benefits of a Bihormonal Bionic Pancreas System in T1D

By

Participants reported improvements in many psychosocial variables associated with using an automated bihormonal bionic pancreas system relative to self-management of diabetes using their own insulin pump.

Remotely Connected Diabetes System Improves Glycemic Control in Insulin-Treated Diabetes

Remotely Connected Diabetes System Improves Glycemic Control in Insulin-Treated Diabetes

By

A remotely connected diabetes management system increased patent satisfaction and improved glycemic control in patients with insulin-treated diabetes.

Effect of Prior Glucose Monitoring on Glycemic Outcomes With a Hybrid Closed-Loop System

Effect of Prior Glucose Monitoring on Glycemic Outcomes With a Hybrid Closed-Loop System

By

Patients with prior experience using a continuous glucose monitoring system may benefit from the MiniMed 670G HCL system therapy.

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Children

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Children

By

Recommendations for utilizing trend arrow data in a mobile continuous glucose monitoring system were recently issued for pediatric patients with type 1 diabetes.

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Adults

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Adults

By

Interpreting trend arrow data from continuous glucose monitoring may provide additional data to improve glycemic control in adults with diabetes mellitus.

Sign Up for Free e-Newsletters



CME Focus